You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Role of Helicobacter pylori in gastric diseases pathogenesis cannot be ignored
  1. Xianzhu Zhou,
  2. Huiyun Zhu,
  3. Yan Chen,
  4. Zhaoshen Li,
  5. Yiqi Du
  1. Department of Gastroenterology, Changhai Hospital, Shanghai, China
  1. Correspondence to Professor Yiqi Du, Department of Gastroenterology, Changhai Hospital, Shanghai 200433, China; duyiqi006{at}126.com

https://doi.org/10.1136/gutjnl-2020-322629

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read with interest the study by Guo et al, evaluating the risk of gastrointestinal bleeding (GIB) in aspirin users after Helicobacter pylori eradication.1 It revealed a higher risk of GIB in new aspirin users even after H. pylori eradication than chronic aspirin users as well as non-users. The propensity score matching method was also performed to balance the potential differences of baseline characteristics among groups, which largely compensate for the deficiencies of retrospective research. However, the prevalence of H. pylori infection among Chinese population remains high (40%–60%).2 3 We hope to explicitly demonstrate the relationship between H. pylori infection and gastric diseases to justify the necessity of H. pylori eradication.

    In our recent retrospective study, …

    View Full Text

    Footnotes

    • Contributors YD and ZL conceived and designed the study, XZ, HZ and YC wrote the draft. All authors final approval of the letter. XZ, HZ and YC contributed equally.

    • Funding This investigation was supported by the grant from National Clinical Research Center for Digestive Diseases of China (2015BAI13B08). HZ is supported by Youth Start-up Fund of Changhai Hospital (Grant No. 2019QNA01). YD is supported by Shanghai Health Commission advanced appropriate technology promotion project (2019SY001).

    • Competing interests None declared.

    • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

    • Provenance and peer review Not commissioned; internally peer reviewed.